E-Technologies STREAM

  1. Overview Of Central eSource From CRIO 6/18/2025

    Central eSource transforms the conduct of clinical trials by replacing disparate, site-specific source templates with a unified, sponsor-designed framework.

  2. Building One Home for Sites 7/23/2024

    Watch this presentation and demonstration of One Home for Sites for the latest updates on how the industry is coming together — even competitors — to alleviate the technology burden on research sites.

  3. Rethinking Today's ePRO Delivery For Tomorrow's Clinical Trials 6/24/2024

    Willie Muehlhausen, Co-CEO and Founder of Safira Clinical Research, and Tim Davis, VP of Strategy at MyVeeva for Patients, discuss how ePRO delivery needs to change to better serve modern trials.

  4. Unleash The Power Of IQVIA Complete Consent 11/12/2024

    Join Vinita Navadgi, and Amy Koller from IQVIA Complete Consent for an in-depth exploration of the eConsent landscape.

  5. Deploy eConsent Around The World With Confidence 8/16/2022

    Explore an easy, secure way to deliver highly engaging, regulatory-compliant electronic consent for trials of all types with IQVIA Complete Consent.

  6. Eliminating Custom Functions From EDC 8/13/2021

    Watch this video to see how companies like ALCON are driving faster study builds and higher quality for complex studies with data-driven rules and dynamics.

  7. Modernizing Clinical Research With AI And Digital Data 3/7/2025

    Discover how ActiGraph is revolutionizing clinical trials with patient-focused digital data and cutting-edge technology that enhances trial efficiency across all phases.

  8. Crossing The TMF Compliance Gap With Inspection-Ready Access For Closed Studies 4/30/2021

    Your drug study is closed, you need inspection-ready access to the Trial Master File, but your CRO is ready to get the TMF out of their system and wants to send you a zip folder full of documents. What do you do? In this session, we explore an innovative new way to ensure your TMF stays secure while remaining accessible to audits and inspectors so you can focus on getting your drug to market and not on finding documents. 

  9. Everything You Need To Know About Adopting eConsent Across Large Pharma Organizations 2/22/2023

    Did you know that the average cost for a delayed trial is between $600,000 and $8 million per day? Discover how electronic consent management technology is helping sponsors, CROs, and sites.

  10. Unleash The Power Of IQVIA eCOA: A Deep Dive 9/10/2024

    Edward Bartels, an expert in eCOA solutions, provides an in-depth overview of the market trends, emerging technologies, and how IQVIA eCOA is pioneering advancements in this space.